AzTrials
AzTrials

Spinal Cord InjuriesNCT04309448

Augmenting Reactive Stepping With FES After SCI

A study testing Perturbation-based balance training with functional electrical stimulation in people with Spinal Cord Injuries, run by University Health Network, Toronto at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Up to 25 individuals living with chronic incomplete spinal cord injury (iSCI) who can stand but have limited ability to elicit a step without physical assistance or upper limb (U/L) support will be recruited for this study. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Spinal Cord Injuries
What is being tested?
Perturbation-based balance training with functional electrical stimulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2 participants
Where
1 siteCanada
Study dates
1 Sep 2019to 30 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • have a motor incomplete SCI (i.e., AIS grade C or D) that is non-progressive;
  • be at least one year post-injury (i.e., chronic injury);
  • ≥ 18 years old;
  • be able to stand independently for 60 sec;
  • unable to take a step bilaterally without physical assistance or upper extremity support;
  • able to understand spoken English;
  • free of any other condition besides SCI that significantly affects walking or balance (e.g., no vestibular disorder, significant vision loss, stroke);
  • be able to provide informed, written consent.

Who cannot join

  • Contraindications for EMS. Electrical stimulation will not be used if:
  • it will be applied to areas where it could cause malfunction of electronic devices, including cardiac pacemakers;
  • a woman is pregnant;
  • the applied region has known or suspected malignancy;
  • the person has active deep vein thrombosis or thrombophlebitis;
  • there are active bleeding tissues, or the person has untreated hemorrhagic disorders;
Show all 14Show fewer
  • there are infected tissues, tuberculosis, or wounds with underlying osteomyelitis;
  • tissues have been radiated in the past six months;
  • there are damaged skin areas or at-risk skin areas that would result in uneven conduction of current;
  • severe spasticity is present in the legs;
  • the person has contractures in the lower limbs that prevent achieving a neutral hip and ankle position, or extended knee;
  • there is a history of prior lower limbs fragility fracture;
  • the leg muscles are unresponsive to electrical stimulation (i.e., peripheral nerve damage in the legs).
  • Pressure sores on pelvis or trunk, where safety harness will be donned.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Lyndhurst Centre, Toronto Rehabilitation Institute-UHN

    Toronto, Ontario, M4G 3V9

Other trials in Canada

About this study

Official title: Augmenting Reactive Stepping With Functional Electrical Stimulation for Individuals Living With Incomplete Spinal Cord Injury

Up to 25 individuals living with chronic incomplete spinal cord injury (iSCI) who can stand but have limited ability to elicit a step without physical assistance or upper limb (U/L) support will be recruited for this study. The first objective of the study will aim to investigate the orthotic effect (i.e., immediate effect) of FES on the reactive stepping response. The second objective is to investigate the therapeutic effect of a novel balance intervention, perturbation-based balance training (PBT) combined with FES (i.e., PBT+FES) on reactive stepping ability, measures of postural sway during quiet standing (i.e., biomechanical measures), and scores on clinical measures of balance and walking.

Being tested
Perturbation-based balance training with functional electrical stimulation
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Perturbation-based balance training with functional electrical stimulationBehavioural

    The PBT program will consist of repetitive practice of reactive stepping for one hour. The participants will be equipped with the Odstock 2-Channel stimulator on one or both sides depending on their deficits. One channel of stimulation may be applied to the common fibular nerve to elicit a flexor withdraw reflex and elicit a step. The second channel of stimulation may be applied to the quadriceps muscles to assist with the supporting phase of the reactive step, as required. Participants will experience about 60 perturbations per session during balance exercises. To create a perturbation, the researcher will apply unexpected pushes or pulls to a safety harness around the participant's trunk. Throughout the hour-long session, participants will complete challenging balance tasks, customized to their ability level, during standing and walking. The training will be supervised by a licensed physiotherapist and administered by a licensed physiotherapist or registered kinesiologist.

Study groups in NCT04309448
Study groupRoleWhat they receive
Perturbation-based balance training with FESExperimentalNot described
Receives: Behavioral: Perturbation-based balance training with functional electrical stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lean-and-release test

    Test of reactive stepping and balance in the forward direction

    Measured: Up to 7 weeks

  2. Biomechanical measures of postural control

    Measurement of centre of pressure during quiet standing

    Measured: Up to 7 weeks

Secondary outcomes (5)
  1. Mini-Balance Evaluation Systems Test

    Assesses four balance control systems

    Measured: Up to 7 weeks

  2. Activities-specific Balance Confidence Scale

    Assesses balance efficacy

    Measured: Up to 7 weeks

  3. Gait parameters

    Step length (cm), gait speed (m/s), double support time (%)

    Measured: Up to 7 weeks

  4. Falls Efficacy Scale International

    Assesses the degree of concern about fear of falling

    Measured: Up to 7 weeks

  5. Semi-structured interview

    Queries the participants' perceived challenges and benefits of the PBT+FES program

    Measured: 3 months post

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2020
  2. Study start1 Sep 2019
  3. Primary completion17 Mar 2020
  4. Study completion30 Jun 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04309448
Sponsor's protocol ID
19-5462
Status last verified
Mar 2021
First submitted
12 Mar 2020
Last updated
1 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Perturbation-based balance training with functional electrical stimulation in people with Spinal Cord Injuries, run by University Health Network, Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lean-and-release test (time frame: Up to 7 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in